Jordi Visser

What happened in the last few weeks is Eli Lilly, which had been under pressure for a period of time, mainly because the uncertainty over what they were gonna do with drug prices.

Drug prices are really critical for

a lot of people in the country and especially voters and inflation.

So we want drug prices to go down.

So Eli Lilly announced, number one, they're building a massive AI drug factory and they announced it with Nvidia.

Number two, for people who don't know, they've had a partnership now for almost two years, if not two years with Google DeepMind.

their lab, which is Isomorphic Labs, and Insilico, this company.

Now, Isomorphic Labs is an AI-generated group from DeepMind where they're trying to solve everything.

So they are the group that had AlphaFold3.

AlphaFold3, which came out two years ago, led to Demis Hassabis.

Actually, AlphaFold3 came out last year.

It led to Demis Hassabis from Google DeepMind, the head, one of the leaders of Google,

getting the Nobel Prize.

And he said in January of this year, and he said it on a 60 Minutes, which everyone should go watch, by the end of this year, we will have AI

drugs going into clinical trials.

Now, what this will do is people will start to realize how much is spent on R&D.

Both time and massive amounts of money where 90% of every drug never even make it to trial.

So the failure rate is very high.

So the amount of money wasted on things, what they're doing is saying, no, this is the blueprint like Moderna that's gonna get you this.

What Insilico does is they're the engineer that goes through and starts creating what would actually work.